The International Association Against Lung Cancer Honors Dr. Luis Montuenga for His Career Path

The International Association for the Study of Lung Cancer (IASLC) today presented the 2026 Adi F. Gazdar Award to Prof. Luis M. Montuenga, principal investigator at Cima Universidad de Navarra, and professor in the faculties of Science and Medicine. The ceremony took place this morning during the IASLC World Conference, held in Seoul, South Korea.

The IASLC Adi F. Gazdar Award for Merit recognizes ongoing contributions in the field of thoracic oncology. Dr. Montuenga receives this award for his career in the study of lung cancer, his leadership in the discovery and validation of biomarkers, and his role in training future professionals dedicated to this disease. Throughout his career, he has contributed to the advancement of strategies aimed at detecting lung cancer at an earlier stage and improving patient selection and treatment. “I am deeply honored to receive this award, which, in reality, belongs to the entire team of researchers, specialists, technicians, and nurses in the field of lung cancer with whom I have collaborated over the past 30 years. They all deserve this award as well,” says the Cima researcher.

Luis Montuenga, a professor of Cell Biology in the Schools of Science and Medicine at the University of Navarra, directs the LUNGSEARCH Biomarker Laboratory at CIMA and serves as principal investigator at the Clínica Universidad de Navarra Cancer Center and at the Navarra Health Research Institute (IdiSNA) and as group leader for the Cancer CIBER (CIBERONC) at the Carlos III Health Institute. He is also a member of the European Academy of Oncology Sciences.